MWA CONSULTING, INC.
  • Home
  • About MWA
  • Consulting Services
  • Industry News
  • Webinars & Podcasts
  • Consulting Opportunities
  • Contact
  • Privacy Policy
Select Page

FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Oct 29, 2021

FDA has announced the new use of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biological products that an establishment manufactured, prepared, propagated, compounded, or processed (including repacking and relabeling) for...


Stay current with FDA regulatory news and compliance trends!

Follow MWA on LinkedIn:

Recent Posts

  • FDA Issued Guidance to Help Identify Suspect and Illegitimate Product in the U.S. Pharmaceutical Distribution Supply Chain
  • FDA Released Draft Guidance on the Use of Electronic Systems, Records, and Signatures in Clinical Investigations
  • FDA Released Recommendations that Assist in the Development of Monoclonal Antibodies (mAbs) and other Therapeutic Proteins
  • New Guidance Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products from FDA
  • FDA Published New Draft Guidance for M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms

Designed by Elegant Themes | Powered by WordPress